-transparent.png){kind=logo}
Primary malignant neoplasms of the pancreas can occur as ductal adenocarcinoma in up to 80% and as a carcinoma of the exocrine or endocrine parenchyma in up to 20%. The treatment of pancreatic cancer is tumor resection. The surgical procedure depends on the tumor site: subtotal pancreatectomy, total or partial duodenopancreatectomy (Whipple's operation). The morbidity ranges from 5 to 15% and the mortality from 2 to 10%. Pancreatic carcinoma has an extremely poor prognosis, the median survival ranges from three to six months, the 5-year survival rate is 2 to 8%. These results are caused by mostly advanced tumors at the time of diagnosis. Early tumor stages with a 5-year survival rate up to 40% account for only 10% of the resected tumors; therefore, after tumor resection, recurrent disease occurs in up to 90%.
E H Farthmann, and
G Ruf
July 2003,
Critical reviews in oncology/hematology,
E H Farthmann, and
G Ruf
September 1980,
Surgical neurology,
E H Farthmann, and
G Ruf
March 2004,
Surgical endoscopy,
E H Farthmann, and
G Ruf
December 1958,
Concours medical,
E H Farthmann, and
G Ruf
July 1953,
El Dia medico,
E H Farthmann, and
G Ruf
May 1996,
Therapeutische Umschau. Revue therapeutique,
E H Farthmann, and
G Ruf
March 1983,
MMW, Munchener medizinische Wochenschrift,
E H Farthmann, and
G Ruf
October 1958,
Journal de chirurgie,
E H Farthmann, and
G Ruf
December 2007,
Zentralblatt fur Chirurgie,
E H Farthmann, and
G Ruf
January 1997,
Wiener medizinische Wochenschrift (1946),
